Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.37 CNY -0.6%
Market Cap: 4.2B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Capital Expenditures
-ÂĄ568.8m
CAGR 3-Years
-64%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Capital Expenditures
-ÂĄ1.5B
CAGR 3-Years
-25%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Capital Expenditures
-ÂĄ64.2m
CAGR 3-Years
27%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Capital Expenditures
-ÂĄ186.2m
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Capital Expenditures
-ÂĄ1.3B
CAGR 3-Years
-58%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Capital Expenditures
-ÂĄ228.4m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
33.69 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Capital Expenditures?
Capital Expenditures
-568.8m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Capital Expenditures amounts to -568.8m CNY.

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-43%

Over the last year, the Capital Expenditures growth was -64%. The average annual Capital Expenditures growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been -64% over the past three years , -43% over the past five years .

Back to Top